Bilateral versus unilateral cases of chronic rhinosinusitis with nasal polyps have notable clinical and laboratory ...
Hosted on MSN2mon
FDA to review GSK’s Nucala for COPDThe study involved 804 COPD patients exhibiting type 2 inflammation, as indicated by blood eosinophil count ... and chronic rhinosinusitis with nasal polyps, but is not currently indicated ...
High GZMK levels were identified in a subset of patients with severe nasal polyps without tissue eosinophilia and type 2 signatures, thus demonstrating the presence of eosinophil- and type 2 ...
EMA accepts for review GSK’s MAA for depemokimab for use in asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 09:00 Hrs [IST] GSK plc announced ...
GSK announces depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 17:00 Hrs [IS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results